Salts of azelastine having improved solubility effective at treating psoriasis and providing a cytoprotective effect

US6017909A · kind A · utility

Assignee

• ASTA Pharma Aktiengesellschaft · DE

Inventors

• Helmut Hettche · Dietzenbach, DE
• Reinhard Muckenschnabel · Frankfurt, DE
• Gerhard Scheffler · Bielefeld, DE
• Ilona Fleischhauer · Offenbach, DE
• Wolfgang Morick · Frankfurt, DE

Key dates

• Filing date: Aug 20, 1998
• Grant date: Jan 25, 2000
• Expiry date: Aug 20, 2018

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Salts of azelastine with acetic acid, gluconic acid, lactic acid or malic acid.